Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.
Follow-Up Questions
Hemagen Diagnostics Inc のCEOは誰ですか？
William Hales は Hemagen Diagnostics Inc の Chairman of the Board で、1999 から在籍しています。
HMGN の株価パフォーマンスは？
HMGN の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Hemagen Diagnostics Inc の主な事業テーマや業界は？
Hemagen Diagnostics Inc は Health Care 業界、セクターは Health Care に属しています。
